Dishman Carbogen Amcis Ltd.
NSE: DCAL | BSE: 540701
₹152.46
₹-1.11
(-0.72%)
As on 07-Oct-2026IST
Market cap
₹2,392 Cr
Revenue (TTM)
₹2,901 Cr
P/E Ratio
148
P/B Ratio
0.4
Div. Yield
0 %
Quality Score
1/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
3/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹16 Cr
-
ROE
1.6 %
-
ROCE
3.2 %
-
Industry P/E
446.68
-
EV/EBITDA
7.8
-
Debt to Equity
0.4
-
Book Value
₹422.2
-
EPS
₹1.2
-
Face value
2
-
Shares outstanding
156,783,095
10 Years Aggregate
CFO
₹3,771.88 Cr
EBITDA
₹4,142.17 Cr
Net Profit
₹439.16 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dishman Carbogen
| -38.4 | -12.6 | -22.2 | -47.0 | -2.1 | -9.3 | -- |
|
BSE Healthcare
| 14.5 | -2.3 | -0.7 | 13.1 | 21.0 | 13.8 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Dishman Carbogen
| -13.2 | 51.1 | 80.1 | -52.9 | 41.8 | 76.7 | -63.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dishman Carbogen
|
152.5 | 2,391.7 | 2,901.5 | 16.2 | 4.7 | 0.3 | 148 | 0.4 |
| 32.2 | 9.9 | 0.2 | 0.0 | 14.4 | 0.5 | 468.9 | 2.5 | |
| 607.1 | 14,603.8 | 3,812.8 | 400.9 | 12.8 | 13.9 | 36.4 | 4.6 | |
| 74.3 | 266.5 | 137.7 | -9.4 | -8.1 | -9.2 | -- | 2.8 | |
| 325.5 | 14,741.4 | 3,171.8 | 521.3 | 19.3 | 18.1 | 28.5 | 4.6 | |
| 26.9 | 806.7 | 1,768.3 | 72.6 | 7.3 | 14.7 | 11.7 | 1.6 | |
| 1,561.8 | 33,107.5 | 2,250.4 | 361.7 | 21.5 | 15.5 | 91.5 | 13.0 | |
| 3,722.9 | 8,580.3 | 949.8 | 266.0 | 35.8 | 72.7 | 32.3 | 24.7 | |
| 12.1 | 180.3 | 84.6 | 12.8 | -2.1 | 20.8 | 14.1 | 5.6 | |
| 15.1 | 33.1 | 55.1 | -2.9 | 17.2 | -16.1 | -- | 0.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Dishman Carbogen
Dishman Carbogen Amcis Limited provides contract development and manufacturing organization (CDMO) services for the pharmaceutical and healthcare industries worldwide. It operates through Integrated CDMO Platform and Marketable Molecules segments.... The company offers cholesterol and vitamin D analogs; soft gel capsules and formulations; intermediate and active pharmaceutical ingredients (APIs) which cover specific therapeutic areas, such as anesthetics, and contrast media agents for diagnostics, ophthalmic treatments, laxatives, and organophosphate antidotes; ammonium and phosphonium; quats, phosphoranes, and wittig reagents; generic intermediates; cholesterol and lanolin-related products; sterile injectables; specialty chemicals and disinfectants, as well as hand and body wash, sanitizers, and antiseptic formulations. It also provides encapsulation and formulation capabilities; phase transfer catalysts; drug product, finished, and HiPo formulations; generic and highpotent APIs; Health and personal care solutions; and drug linkers and payloads. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP. Read more
-
Incorporated
2007
-
Chairman
--
-
Managing Director
Arpit J Vyas
-
Group
Dishman Pharma
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Dishman Carbogen Amcis Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Dishman Carbogen
What is the current share price of Dishman Carbogen Amcis Ltd Today?
The share price of Dishman Carbogen Amcis Ltd is ₹152.46 (NSE) and ₹152.55 (BSE) as of 07-Oct-2026 IST. Dishman Carbogen Amcis Ltd has given a return of -2.06% in the last 3 years.
What is the current PB & PE ratio of Dishman Carbogen Amcis Ltd?
The P/E ratio of Dishman Carbogen Amcis Ltd is 148.00 times as on 07-Oct-2026, a 67 discount to its peers’ median range of 446.68 times.
The P/B ratio of Dishman Carbogen Amcis Ltd is 0.36 times as on 07-Oct-2026, a 85 discount to its peers’ median range of 2.38 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
20.92 |
0.31 |
2025 |
1,053.08 |
0.59 |
2024 |
0.00 |
0.66 |
2023 |
0.00 |
0.34 |
2022 |
161.20 |
0.52 |
What is the 52 Week High and Low of Dishman Carbogen Amcis Ltd?
The 52-week high and low of Dishman Carbogen Amcis Ltd are Rs 306.00 and Rs 128.50 as of 07-Oct-2026.
What is the market cap of Dishman Carbogen Amcis Ltd?
Dishman Carbogen Amcis Ltd has a market capitalisation of ₹ 2,392 Cr as on 07-Oct-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Dishman Carbogen Amcis Ltd?
Before investing in Dishman Carbogen Amcis Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.